SCHEDULE: Laksya Ventures & Neil Persh Disclose 9.6% Stake in Lunai Bioworks

Laksya Ventures Inc. and Neil Persh jointly reported a 9.6% beneficial ownership stake in Lunai Bioworks Inc., primarily through convertible note conversions.

Summary

• Laksya Ventures Inc. and Neil Persh jointly reported beneficial ownership of 22,163,978 shares of Lunai Bioworks Inc. common stock.
• This represents 9.6% of Lunai Bioworks Inc.'s total outstanding shares, based on 230,928,963 shares as of July 15, 2025.
• The ownership includes 18,997,168 shares issued to Laksya Ventures upon conversion of convertible notes, 500,000 shares held directly by Laksya Ventures, and 2,666,810 shares held directly by Mr. Persh.
• Neil Persh, who controls Laksya Ventures, exercises sole voting and investment power over all beneficially owned shares.

Sentiment

Score: 7

Explanation: The disclosure of a significant 9.6% passive stake by Laksya Ventures and Neil Persh, largely from convertible note conversions, suggests a long-term commitment and potential confidence in Lunai Bioworks Inc. This is generally viewed as a positive signal for the company's stability and future prospects, without indicating any immediate negative implications.

Positives

• Disclosure of a significant 9.6% beneficial ownership by Laksya Ventures Inc. and Neil Persh may signal confidence in Lunai Bioworks Inc.
• The conversion of convertible notes into common stock by Laksya Ventures Inc. indicates a long-term commitment to the company.

Future Outlook

The filing does not provide any forward-looking statements or guidance from Lunai Bioworks Inc. or the reporting persons regarding the issuer's future performance.

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Industry Context

This filing is a standard disclosure of a significant passive investment. It does not provide specific industry trends or competitive analysis. A 9.6% stake is substantial and could be viewed positively by the market as a vote of confidence in the biotechnology sector or Lunai Bioworks specifically.

Comparison to Industry Standards

• The filing is a regulatory disclosure of beneficial ownership and does not contain information for direct comparison to industry-specific operational or financial benchmarks.
• A 9.6% stake is a significant passive investment, typically indicating a long-term interest without immediate intent to influence management, which is common for institutional investors in emerging biotech companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial owner can provide increased transparency and potentially boost investor confidence.

Key Dates

Recommendation

The Schedule 13G filing indicates a significant passive ownership stake of 9.6% in Lunai Bioworks Inc. by Laksya Ventures Inc. and Neil Persh, largely resulting from the conversion of convertible notes. This suggests a long-term commitment and confidence from a major investor. However, as a passive ownership disclosure, it does not provide new operational or financial performance data that would typically drive a 'buy' or 'sell' recommendation. The existing stake and its nature support a 'hold' position, awaiting further company-specific news or financial results for a more definitive investment decision.

Keywords

Lunai Bioworks, Laksya Ventures, Neil Persh, SEC filing, Schedule 13G, beneficial ownership, common stock, convertible notes, bioworks, biotechnology